🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

1ry Versus 2ry ILM Peeling in RD

RecruitingNAAges 18 Years - anyAllSohag University
NCT07346560 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients with uncomplicated rhegmatogenous retinal detachment will be recruited. All eyes will underwent 23G PPV with silicon oil tamponade. The eyes will be classified into two groups according to the timing of ILM peeling. Group A, ILM peelin will be performed during the first intervention, while in group B, it will be done at the time of silicon oil extraction.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with uncomplicated rhegmatogenous retinal detcahment. Exclusion Criteria: * PVR * Recurrent RD * Tractional RD * Macular hole RD * Scleral buckling is indicated * Macular scarring * Previous PPV
💊

What it tests

  • Primary ILM peeling
  • Secondary ILM peeling
📍

Where

1 site
Sohag Faculty of Medicine
Sohag, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy